<DOC>
	<DOCNO>NCT01077804</DOCNO>
	<brief_summary>The purpose continue post-licensure study evaluate long-term effectiveness VARIVAXÂ® [ Varicella Virus Vaccine Live ( Oka/Merck ) ] assess impact vaccine epidemiology varicella herpes zoster .</brief_summary>
	<brief_title>A Study Evaluate Long-term Impact VARIVAX Among Children Adolescents ( V210-036 ) ( COMPLETED )</brief_title>
	<detailed_description>Parents/guardians cohort child vaccinate 12 23 month age six-month period 1995 ( June-November ) KPMCP Northern California interview telephone 6-month interval ascertain whether child varicella herpes zoster 6 month prior interview . Follow-up continue minimum 14 year vaccination .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<criteria>Subject member Kaiser Permanente Northern California , age 1223 month , receive dose varicella vaccine June November 1995 , parent accept participate 15year followup Subjects diagnose varicella study enrollment Subject 's parent unable complete telephone interview English , Spanish , Cantonese</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>